Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Goodwill (2016 - 2017)

IGC Pharma (IGC) has disclosed Goodwill for 6 consecutive years, with $198169.0 as the latest value for Q4 2017.

  • On a quarterly basis, Goodwill changed 0.09% to $198169.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $198169.0, a 0.09% change, with the full-year FY2017 number at $198169.0, down 83.22% from a year prior.
  • Goodwill was $198169.0 for Q4 2017 at IGC Pharma, roughly flat from $198169.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $1.2 million in Q1 2016 to a low of $198000.0 in Q4 2016.
  • A 4-year average of $733483.5 and a median of $982782.0 in 2014 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: rose 20.16% in 2016, then crashed 83.22% in 2017.
  • IGC Pharma's Goodwill stood at $982782.0 in 2014, then changed by 0.0% to $982782.0 in 2015, then tumbled by 79.85% to $198000.0 in 2016, then grew by 0.09% to $198169.0 in 2017.
  • Per Business Quant, the three most recent readings for IGC's Goodwill are $198169.0 (Q4 2017), $198169.0 (Q2 2017), and $198169.0 (Q1 2017).